UCB, a global biopharmaceutical company, announced it will present 26 abstracts from its epilepsy portfolio at the upcoming International Epilepsy Congress (IEC) in Lisbon, Portugal, from August 30 to September 3, 2025.
UCB, A Global Biopharmaceutical Company | 30/08/2025 | By Darshana | 211
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy